<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00797121</url>
  </required_header>
  <id_info>
    <org_study_id>SUMS-5010</org_study_id>
    <secondary_id>Cholangiocarcinoma</secondary_id>
    <secondary_id>Surgery</secondary_id>
    <secondary_id>Drainage</secondary_id>
    <nct_id>NCT00797121</nct_id>
  </id_info>
  <brief_title>Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma</brief_title>
  <official_title>Effect of Preoperative Biliary Drainage on Postoperative Complications in Resectable Patients With Hilar Cholangiocarcinoma(Klatskin Tumor)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate whether preoperative biliary drainage can reduce the
      postoperative morbidity in patients with hilar cholangiocarcinoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative biliary drainage(PBD) or not, is a Hot Spot issue in the management of Hilar
      cholangiocarcinoma. Surgeons from Japan tend to perform PTBD(Percutaneous Transhepatic
      Biliary Drainage) before a definite operation until the total bilirubin(TB) lower than
      85μmol/L. For some patients needed to perform extended curative resection, PVE(Portal Vein
      Embolization) is performed and thus the duration of PBD may be around six weeks and the final
      TB is lower than 34μmol/L. Some tend to perform a definite curative operation in a short time
      after diagnosis. There is no RCT research on the effect of PBD for the resectable Hilar
      Cholangiocarcinoma patients to date.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">May 2013</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative complication</measure>
    <time_frame>30 days after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative mortality</measure>
    <time_frame>30 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival, OS</measure>
    <time_frame>May, 2013</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease free survival, DFS</measure>
    <time_frame>May, 2013</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <condition>Drainage</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Preoperative biliary drainage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Controlled group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Preoperative biliary drainage</intervention_name>
    <description>Percutaneous transhepatic biliary drainage(PTBD) is performed under the guidance of ultrasound. The duration may be around four weeks to make the total bilirubin of patients lower than 85μmol/L.</description>
    <arm_group_label>Preoperative biliary drainage</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients newly diagnosed

          -  Resectable patients after imaging assessment and evaluation of general condition of
             the patient

          -  TB&gt;85μmol/L

          -  WBC account more than 1.5×109/L, PLT account more than 100×109/L and HB account more
             than 100g/L

          -  No serious disease in heart, lung and kidney

          -  Written informed consent

        Exclusion Criteria:

          -  Unresectable patients.

          -  Patients have received biliary drainage procedure such as PTBD before admission

          -  Complicated with chronic hepatitis

          -  Myocardia infarction record within six months

          -  Women in pregnancy

          -  Serious disease in heart, lung or kidney
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lijian Liang</last_name>
    <role>Study Chair</role>
    <affiliation>Department of hepatobiliary, the first affiliated hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiaoyu Yin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lijian Liang</last_name>
    <phone>86-20-87755766</phone>
    <phone_ext>8096</phone_ext>
    <email>lianglj@medmail.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Hepatobiliary, the first affiliated hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Chen, MD</last_name>
      <phone>86-20-87755766</phone>
      <phone_ext>8096</phone_ext>
      <email>gzbobsums2004@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Lijian Liang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9.</citation>
    <PMID>11573044</PMID>
  </reference>
  <reference>
    <citation>Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayakawa N. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg. 2000;7(2):155-62.</citation>
    <PMID>10982608</PMID>
  </reference>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2008</study_first_submitted>
  <study_first_submitted_qc>November 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2008</study_first_posted>
  <last_update_submitted>November 24, 2008</last_update_submitted>
  <last_update_submitted_qc>November 24, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2008</last_update_posted>
  <responsible_party>
    <name_title>Liang Li-jian</name_title>
    <organization>the First affiliated hospital, Sun Yat-Sen University</organization>
  </responsible_party>
  <keyword>Cholangiocarcinoma</keyword>
  <keyword>Drainage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Klatskin Tumor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

